DD126929A5 - - Google Patents

Info

Publication number
DD126929A5
DD126929A5 DD195241A DD19524176A DD126929A5 DD 126929 A5 DD126929 A5 DD 126929A5 DD 195241 A DD195241 A DD 195241A DD 19524176 A DD19524176 A DD 19524176A DD 126929 A5 DD126929 A5 DD 126929A5
Authority
DD
German Democratic Republic
Application number
DD195241A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD126929A5 publication Critical patent/DD126929A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DD195241A 1975-10-13 1976-10-12 DD126929A5 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41887/75A GB1566706A (en) 1975-10-13 1975-10-13 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
DD126929A5 true DD126929A5 (cg-RX-API-DMAC7.html) 1977-08-24

Family

ID=10421810

Family Applications (1)

Application Number Title Priority Date Filing Date
DD195241A DD126929A5 (cg-RX-API-DMAC7.html) 1975-10-13 1976-10-12

Country Status (28)

Country Link
US (3) US4256638A (cg-RX-API-DMAC7.html)
JP (1) JPS5248686A (cg-RX-API-DMAC7.html)
AR (1) AR213294A1 (cg-RX-API-DMAC7.html)
AT (1) AT352874B (cg-RX-API-DMAC7.html)
AU (1) AU503489B2 (cg-RX-API-DMAC7.html)
BE (1) BE847044A (cg-RX-API-DMAC7.html)
CA (1) CA1094563A (cg-RX-API-DMAC7.html)
CH (2) CH634323A5 (cg-RX-API-DMAC7.html)
DD (1) DD126929A5 (cg-RX-API-DMAC7.html)
DE (1) DE2646003A1 (cg-RX-API-DMAC7.html)
DK (1) DK457676A (cg-RX-API-DMAC7.html)
ES (2) ES452361A1 (cg-RX-API-DMAC7.html)
FI (1) FI762895A7 (cg-RX-API-DMAC7.html)
FR (1) FR2327775A1 (cg-RX-API-DMAC7.html)
GB (1) GB1566706A (cg-RX-API-DMAC7.html)
GR (1) GR61674B (cg-RX-API-DMAC7.html)
HU (1) HU175046B (cg-RX-API-DMAC7.html)
IE (1) IE43840B1 (cg-RX-API-DMAC7.html)
IL (1) IL50618A (cg-RX-API-DMAC7.html)
MX (1) MX4688E (cg-RX-API-DMAC7.html)
NL (1) NL7611206A (cg-RX-API-DMAC7.html)
NO (3) NO763472L (cg-RX-API-DMAC7.html)
NZ (1) NZ182190A (cg-RX-API-DMAC7.html)
PT (1) PT65707B (cg-RX-API-DMAC7.html)
SE (3) SE7611047L (cg-RX-API-DMAC7.html)
SU (1) SU639454A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA765901B (cg-RX-API-DMAC7.html)
ZM (1) ZM12276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53116395A (en) * 1976-10-25 1978-10-11 Glaxo Lab Ltd Novel antibiotics and process for preparing same
US4359473A (en) 1977-04-22 1982-11-16 Beecham Group Limited α-Amino deoxy clavulanic acid antibacterial agents
GB1604822A (en) 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
EP0005014A1 (en) * 1978-04-22 1979-10-31 Beecham Group Plc Clavulanic acid derivatives, preparation and compositions
DE2963534D1 (en) * 1978-07-29 1982-10-07 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them
EP0008884B1 (en) * 1978-09-09 1983-08-17 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their compositions
ATE5143T1 (de) * 1978-09-09 1983-11-15 Beecham Group Plc Clavulansaeure-derivate und verfahren zu ihrer herstellung.
EP0008877B1 (en) * 1978-09-09 1983-10-26 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
DE2965938D1 (en) 1978-10-25 1983-08-25 Beecham Group Plc Clavulanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
IL60343A0 (en) * 1979-07-02 1980-09-16 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
DE3066511D1 (en) * 1979-10-26 1984-03-15 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
JPS57143194A (en) * 1981-02-27 1982-09-04 Matsushita Electric Ind Co Ltd Blower
EP0062407A1 (en) * 1981-03-10 1982-10-13 Beecham Group Plc Therapeutic compounds containing beta-lactams
JPH0495698U (cg-RX-API-DMAC7.html) * 1991-01-21 1992-08-19
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1424186A (en) * 1971-10-08 1976-02-11 Beecham Group Ltd Penicillins
US3925363A (en) * 1974-01-17 1975-12-09 Merck & Co Inc Process for epimerizing penicillin compounds, and related products
US4051132A (en) * 1974-01-23 1977-09-27 Merck & Co., Inc. Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench
GB1585165A (en) * 1976-06-29 1981-02-25 Leo Pharm Prod Ltd Derivatives of 6-amidino penicillanic acid
IL54859A (en) * 1977-06-21 1982-01-31 Rech Applications Therap Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
US4244965A (en) * 1978-06-15 1981-01-13 Beecham Group Limited Azetidinoyl ethers
US4252722A (en) * 1979-08-08 1981-02-24 Merck & Co., Inc. Process for the preparation of 6-hydroxymethyl-2-(β-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents

Also Published As

Publication number Publication date
CA1094563A (en) 1981-01-27
FR2327775A1 (fr) 1977-05-13
NZ182190A (en) 1979-03-16
CH634323A5 (de) 1983-01-31
CH639665A5 (de) 1983-11-30
US4382084A (en) 1983-05-03
ES463974A1 (es) 1978-12-16
SE8004329L (sv) 1980-06-10
PT65707B (en) 1978-04-17
DE2646003A1 (de) 1977-04-21
US4438101A (en) 1984-03-20
NO802662L (no) 1977-04-14
IL50618A0 (en) 1976-12-31
PT65707A (en) 1976-11-01
FI762895A7 (cg-RX-API-DMAC7.html) 1977-04-14
AU503489B2 (en) 1979-09-06
DK457676A (da) 1977-04-14
IE43840L (en) 1977-04-13
SE8004330L (sv) 1980-06-10
US4256638A (en) 1981-03-17
SU639454A3 (ru) 1978-12-25
JPS612670B2 (cg-RX-API-DMAC7.html) 1986-01-27
AT352874B (de) 1979-10-10
GB1566706A (en) 1980-05-08
BE847044A (fr) 1977-04-07
ES452361A1 (es) 1978-01-01
ZA765901B (en) 1977-09-28
SE7611047L (sv) 1977-04-14
AR213294A1 (es) 1979-01-15
NO802661L (no) 1977-04-14
NO763472L (cg-RX-API-DMAC7.html) 1977-04-14
ZM12276A1 (en) 1977-07-21
HU175046B (hu) 1980-05-28
AU1858276A (en) 1978-04-20
MX4688E (es) 1982-08-02
IL50618A (en) 1979-09-30
IE43840B1 (en) 1981-06-03
ATA753476A (de) 1979-03-15
JPS5248686A (en) 1977-04-18
NL7611206A (nl) 1977-04-15
FR2327775B1 (cg-RX-API-DMAC7.html) 1978-11-17
GR61674B (en) 1978-12-05

Similar Documents

Publication Publication Date Title
FR2321567B1 (cg-RX-API-DMAC7.html)
FR2327775B1 (cg-RX-API-DMAC7.html)
JPS5525095Y2 (cg-RX-API-DMAC7.html)
FI760640A7 (cg-RX-API-DMAC7.html)
JPS5551572Y2 (cg-RX-API-DMAC7.html)
JPS5628910B2 (cg-RX-API-DMAC7.html)
JPS51137649U (cg-RX-API-DMAC7.html)
JPS521198U (cg-RX-API-DMAC7.html)
CH597750A5 (cg-RX-API-DMAC7.html)
CH607228A5 (cg-RX-API-DMAC7.html)
CH597482A5 (cg-RX-API-DMAC7.html)
CH597501A5 (cg-RX-API-DMAC7.html)
BG21162A1 (cg-RX-API-DMAC7.html)
BG22513A1 (cg-RX-API-DMAC7.html)
CH600675A5 (cg-RX-API-DMAC7.html)
CH576092A5 (cg-RX-API-DMAC7.html)
CH603493A5 (cg-RX-API-DMAC7.html)
CH596331A5 (cg-RX-API-DMAC7.html)
CH611832A5 (cg-RX-API-DMAC7.html)
CH608525A5 (cg-RX-API-DMAC7.html)
CH602916A5 (cg-RX-API-DMAC7.html)
CH595243A5 (cg-RX-API-DMAC7.html)
CH596119A5 (cg-RX-API-DMAC7.html)
CH590999A5 (cg-RX-API-DMAC7.html)
CH602830A5 (cg-RX-API-DMAC7.html)